Retraction Note: miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1.
Biotechnol Lett. 2023 Jan 10. doi: 10.1007/s10529-023-03344-4. Online ahead of print.
Biotechnol Lett. 2023.
PMID: 36626104
No abstract available.